doi:10.1056/NEJMoa1411892 91
[52] GLP: Glucagon-like peptide, GLP-1 RA: Glucagon-like peptide 1 receptor agonist, GI: Gastrointestinal Implications of GLP-1RA in critical care The action of GLP-1 agonists can have significant implications for the management of critically ill patients in terms of gastric emptying, tolerance of enteral nutrition, and glycaemic control
4,19,20 Postmarketing data include reports of serious urinary tract infections (UTIs) with SGLT2 inhibitors, including urosepsis and pyelonephritis requiring hospitalization
12-14 In phase III clinical studies in which exenatide was administered concomitantly with metformin, an SU, or metformin plus an SU, 48% of the 483 patients receiving exenatide 10 mcg twice daily reported nausea compared to 18% of the 483 patients receiving placebo
Akkermansia muciniphila : a potential novel mechanism of nuciferine to improve hyperlipidemia